https://itbusinessnet.com/2022/04/u-s-food-and-drug-administration-approves-camzyos-mavacamten-for-the-treatment-of-adults-with-symptomatic-new-york-heart-association-class-ii-iii-obstructive-hypertrophic-cardiomyopathy-hcm-to-im/
U.S. Food and Drug Administration Approves Camzyos (mavacamten) for the Treatment of Adults with...
food and drug administration
https://connect.mayoclinic.org/discussion/camzyos-mavacamten-prescription/
Anyone take new drug Camzyos (mavacamten) for HCM? | Mayo Clinic Connect
Since FDA approval in April has anyone (non-clinical trial patient) actually obtained a prescription and had it filled? If so, when and where was the...
new drugmayo clinicanyonetakecamzyos